These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 31567925)

  • 1. Differential Survival Benefits of 5-Fluorouracil-Based Adjuvant Chemotherapy for Patients With Microsatellite-Stable Stage III Colorectal Cancer According to the Tumor Budding Status: A Retrospective Analysis.
    Yamadera M; Shinto E; Kajiwara Y; Mochizuki S; Okamoto K; Hase K; Yamamoto J; Ueno H
    Dis Colon Rectum; 2019 Nov; 62(11):1316-1325. PubMed ID: 31567925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a Preoperative Leisure-Time Physical Activity With Short- and Long-term Outcomes of Patients Undergoing Curative Resection for Stage I to III Colorectal Cancer: A Propensity Score Matching Analysis.
    You JF; Hsu YJ; Chern YJ; Hung HY; Hsieh PS; Yeh CY; Chiang JM; Tsai WS
    Dis Colon Rectum; 2020 Jun; 63(6):796-806. PubMed ID: 32118625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naples Prognostic Score Is a Useful Prognostic Marker in Patients With Metastatic Colorectal Cancer.
    Miyamoto Y; Hiyoshi Y; Daitoku N; Okadome K; Sakamoto Y; Yamashita K; Kuroda D; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Baba H
    Dis Colon Rectum; 2019 Dec; 62(12):1485-1493. PubMed ID: 31567920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age Determines Adjuvant Chemotherapy Use in Resected Stage II Colon Cancer.
    Hagerty BL; Aversa JG; Dominguez DA; Davis JL; Hernandez JM; McCormick JT; Blakely AM
    Dis Colon Rectum; 2022 Oct; 65(10):1206-1214. PubMed ID: 34897212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of an Enhanced Recovery Protocol Is Associated With On-Time Initiation of Adjuvant Chemotherapy in Colorectal Cancer.
    Hassinger TE; Mehaffey JH; Martin AN; Bauer-Nilsen K; Turrentine FE; Thiele RH; Sarosiek BM; Reilley MJ; Hoang SC; Friel CM; Hedrick TL
    Dis Colon Rectum; 2019 Nov; 62(11):1305-1315. PubMed ID: 31567924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is High-Grade Tumor Budding an Independent Prognostic Factor in Stage II Colon Cancer?
    Kyong Shin J; Ah Park Y; Wook Huh J; Hyeon Yun S; Cheol Kim H; Yong Lee W; Hyung Kim S; Yun Ha S; Cho YB
    Dis Colon Rectum; 2023 Aug; 66(8):e801-e808. PubMed ID: 35394982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival.
    Chen PJ; Li TL; Sun TT; Willis VC; Roebuck MC; Bravata DM; Liu XZ; Arriaga YE; Dankwa-Mullan I; Wu AW
    Dis Colon Rectum; 2020 Oct; 63(10):1383-1392. PubMed ID: 32969881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Population-Based Cohort Study of Venous Thromboembolism Rates Following Surgery and During Adjuvant Chemotherapy in Patients With Colon Cancer.
    Patel SV; Zhang L; Wei XS; Merchant SJ; Nanji S; James PD; Booth CM
    Dis Colon Rectum; 2020 Mar; 63(3):336-345. PubMed ID: 32045399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
    Narasimhan V; Britto M; Pham T; Warrier S; Naik A; Lynch AC; Michael M; Tie J; Ramsay R; Heriot A
    Dis Colon Rectum; 2019 Oct; 62(10):1195-1203. PubMed ID: 31490828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Microsatellite Status Associated With Prognosis in Stage II Colon Cancer With High-Risk Features?
    Cavallaro PM; Stafford C; Cauley CE; Berger DL; Bordeianou L; Kunitake H; Francone T; Ricciardi R
    Dis Colon Rectum; 2021 May; 64(5):545-554. PubMed ID: 33939386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Tumor-Related Complications Among Patients With Unresectable Stage IV Colorectal Cancer in the Era of Targeted Therapy: A Competing Risk Regression Analysis.
    Tanabe T; Shida D; Boku N; Yoshida T; Tsukamoto S; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Sep; 64(9):1074-1082. PubMed ID: 34397558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple High-Risk Features for Stage II Colon Carcinoma Portends Worse Survival Than Stage III Disease.
    Hajirawala LN; Yi Y; Herritt BC; Laurent ME; Klinger AL; Orangio GR; Davis KG; Barton JS
    Dis Colon Rectum; 2023 Aug; 66(8):1076-1084. PubMed ID: 35239528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Characteristics of Patients With Colorectal Cancer Who Have Benign Mesenteric Lymph Node Enlargement: A Multi-institutional Cohort Study.
    Huang X; Yang Y; Liu Q; Tang X; Shi J; Qu H; Chen X; Gong L; Wang S; Tang S; Wang P; Tang L; Hu D; Yin X; Guan Y; Kong D; Tian F
    Dis Colon Rectum; 2022 Jun; 65(6):804-816. PubMed ID: 34759241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated With Adjuvant Chemotherapy Noncompliance and Survival in Older Adults With Stage III Colon Cancer.
    Simon HL; Reif de Paula T; Spigel ZA; Keller DS
    Dis Colon Rectum; 2023 Sep; 66(9):1254-1262. PubMed ID: 36574320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Work Ability in Patients With Stage I to IV Colon Cancer: Results of the Dutch Prospective Colorectal Cancer Cohort.
    Franken MD; Vink G; van Grevenstein WMU; Verkooijen HM; Punt CJA; Koopman M; May AM;
    Dis Colon Rectum; 2023 Jan; 66(1):50-58. PubMed ID: 34753892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
    Nakamura Y; Shida D; Boku N; Yoshida T; Tanabe T; Takamizawa Y; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Nov; 64(11):1331-1341. PubMed ID: 34623347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and Outcomes of Upstaging in Rectal Cancer Patients Who Did Not Receive Preoperative Therapy.
    Antunez AG; Kanters AE; Regenbogen SE
    Dis Colon Rectum; 2023 Jan; 66(1):59-66. PubMed ID: 35905174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Impact of Lymphatic Invasion, Venous Invasion, Perineural Invasion, and Tumor Budding in Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision.
    Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park YA; Shin JK
    Dis Colon Rectum; 2023 Jul; 66(7):905-913. PubMed ID: 35195558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perineural Invasion Is a Prognostic but not a Predictive Factor in Nonmetastatic Colon Cancer.
    Leijssen LGJ; Dinaux AM; Taylor MS; Deshpande V; Kunitake H; Bordeianou LG; Berger DL
    Dis Colon Rectum; 2019 Oct; 62(10):1212-1221. PubMed ID: 31490830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.